ITALY PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET ANALYSIS
The market opportunities for key players to enter into this market are high owing to less competition and increasing demand for peptide receptor radionuclide therapy in the Italy market. Moreover, increasing incidence of cancer in Italy is directly contributing to demand for PRRT therapy. These factors are creating growth opportunities for companies to focus on research and development of new drugs. As per the Italian Association of Medical Oncology’s report, in April 2019, 71,000 new cases were diagnosed with new additional cancer cases.
Key player operating in the Italy Peptide Receptor Radionuclide Therapy (PRRT) Market is Novartis International AG.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
